Rankings · Growth
Fastest-growing A-graded companies
Graded A, with more than $1B of revenue now and at least $250M three years ago, ranked by how fast revenue grew each year over those three years — the same comparison the grade’s own “revenue growing overall” check makes.
49 companies meet this test
Figures as of November 15, 2026
| # | Company | Grade | Revenue growth | Free cash flow growth | Net margin | Market value |
|---|---|---|---|---|---|---|
| 1 | CAICARIS LIFE SCIENCES, INC. | A | +51% a year | — | 9.2% | $6.6B |
| 2 | OSCROscar Health, Inc. | A | +48% a year | — | 4.9% | $9.6B |
| 3 | ONCBEONE MEDICINES LTD. | A+ | +44% a year | — | 13.9% | $47.6B |
| 4 | LLYELI LILLY AND COMPANY | A+ | +39% a year | +81% a year | 31.9% | $1.36T |
| 5 | HALOHALOZYME THERAPEUTICS, INC. | A+ | +32% a year | +36% a year | 26.9% | $11.4B |
| 6 | NBIXNEUROCRINE BIOSCIENCES, INC. | A+ | +28% a year | +39% a year | 19.0% | $16.9B |
| 7 | BTSGBrightSpring Health Services, Inc. | A | +26% a year | +53% a year | 2.7% | $14.2B |
| 8 | PACSPACS Group, Inc. | A | +22% a year | — | 4.9% | $7.7B |
| 9 | ISRGIntuitive Surgical, Inc. | A+ | +19% a year | +42% a year | 25.5% | $153.8B |
| 10 | LFSTLifeStance Health Group, Inc. | A | +19% a year | — | 4.3% | $5.4B |
| 11 | EWEDWARDS LIFESCIENCES CORPORATION | A+ | +17% a year | +21% a year | 15.3% | $61.6B |
| 12 | PENPenumbra, Inc | A | +16% a year | — | 10.1% | $12.6B |
| 13 | RDNTRadNet, Inc. | A- | +15% a year | — | -0.9% | $6B |
| 14 | INNVInnovAge Holding Corp. | A | +13% a year | — | 0.9% | $1.3B |
| 15 | HQYHEALTHEQUITY, INC. | A+ | +13% a year | +32% a year | 17.4% | $8.6B |
| 16 | AMGNAmgen Inc. | A+ | +13% a year | +1% a year | 24.1% | $251.9B |
| 17 | MCKMcKESSON CORPORATION | A | +13% a year | +16% a year | 1.1% | $127.3B |
| 18 | EXELEXELIXIS, INC. | A+ | +12% a year | +48% a year | 35.5% | $16.8B |
| 19 | BLCOBausch & Lomb Corp | A- | +11% a year | — | -2.0% | $7.5B |
| 20 | EHCEncompass Health Corporation | A+ | +11% a year | +19% a year | 10.2% | $13.8B |
| 21 | SYKSTRYKER CORP | A+ | +10% a year | +21% a year | 13.8% | $117.9B |
| 22 | MDLNMedline Inc. | A | +10% a year | +10% a year | 2.9% | $51.9B |
| 23 | NVSNovartis AG | A | +9% a year | +10% a year | -0.1% | $306.3B |
| 24 | BHCBausch Health Companies Inc. | A | +9% a year | +26% a year | -7.6% | $3.1B |
| 25 | IDXXIDEXX LABORATORIES INC /DE | A+ | +9% a year | +24% a year | 25.4% | $55.5B |
More rankings
A ranking orders companies by one stated measure. It is not a recommendation, and it says nothing about whether any share price is reasonable.